Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)
IRVINE, Calif.--(BUSINESS WIRE)--Oct. 17, 2018--
Masimo (NASDAQ: MASI) announced today that it will release third quarter
2018 financial results for the period ended September 29, 2018, after
the market closes on Wednesday, October 31, 2018. The conference call to
review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be
hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah
Young, Executive Vice President and Chief Financial Officer.
A live webcast of the conference call will be available online from the
investor relations page of the company's corporate website at www.masimo.com.
The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706)
758-3929 for international callers. The reservation code for both
dial-in numbers is 2368156. After the live webcast, the call will be
available on Masimo's website through November 28, 2018. In addition, a
telephonic replay of the call will be available through November 7,
2018. The replay dial-in numbers are (855) 859-2056 for domestic callers
and +1 (404) 537-3406 for international callers. Please use reservation
code 2368156.
About Masimo
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive
monitoring technologies. Our mission is to improve patient outcomes and
reduce the cost of care. In 1995, the company debuted Masimo SET®
Measure-through Motion and Low Perfusion™ pulse oximetry, which has been
shown in multiple studies to significantly reduce false alarms and
accurately monitor for true alarms. In 2005, Masimo introduced rainbow®
Pulse CO-Oximetry technology, allowing noninvasive and continuous
monitoring of blood constituents that previously could only be measured
invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), Pleth Variability
Index (PVi®), and more recently, Oxygen Reserve Index (ORi™), in
addition to SpO2, pulse rate, and perfusion index (Pi). In 2014, Masimo
introduced Root®, an intuitive patient monitoring and connectivity
platform with the Masimo Open Connect™ (MOC-9™) interface, enabling
other companies to augment Root with new features and measurement
capabilities. Masimo is also taking an active leadership role in mHealth
with products such as the Radius-7™ wearable patient monitor, iSpO2®
pulse oximeter for smartphones, and the MightySat™ fingertip pulse
oximeter. Additional information about Masimo and its products may be
found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome
and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites
and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks
or registered trademarks of Masimo.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181017005232/en/
Source: Masimo
Masimo
Investor Contact:
Eli Kammerman,
949-297-7077
ekammerman@masimo.com
or
Media
Contact:
Irene Paigah, 858-859-7001
irenep@masimo.com